Peripheral Dopamine Directly Acts on Insulin-Sensitive Tissues to Regulate Insulin Signaling and Metabolic Function

Area of Science:

• Endocrinology
• Neuroscience
• Metabolic Research

Background:

• Dopamine regulates central nervous system glucose metabolism.
• Peripheral dopamine may directly impact insulin-sensitive tissues.
• Bromocriptine, a D2R agonist, is FDA-approved for type 2 diabetes.

Purpose of the Study:

• To investigate the role of peripheral dopamine and its receptors in glucose uptake and metabolism.
• To examine dopamine's effects on insulin-sensitive tissues (liver, muscle, adipose).

Main Methods:

• In vivo studies in rats measuring [3H]2-deoxyglucose uptake.
• Ex vivo analysis of glucose uptake, insulin receptor phosphorylation, and metabolic function.
• Pharmacological manipulation using dopamine agonists and antagonists (bromocriptine, domperidone, haloperidol).

Main Results:

• Peripheral dopamine increased glucose uptake in vivo.
• Ex vivo, dopamine stimulated soleus muscle uptake; bromocriptine enhanced liver uptake.
• Dopamine and bromocriptine modulated insulin-induced glucose uptake and signaling pathways (Akt, AMPK) in adipose tissue and soleus muscle.

Conclusions:

• Peripheral dopamine stimulates glucose uptake via differentially involved dopamine receptors.
• Dopamine influences lipid metabolism in white adipose tissue.
• Modulating the peripheral dopaminergic system may offer therapeutic potential for metabolic disorders.